Keith Speights
TMFFishBiz
Keith Speights is a contributing Motley Fool healthcare analyst covering publicly traded companies across pharmaceuticals, biotechnology, medical devices, technology, and marijuana. Prior to The Motley Fool, Keith was CEO of Constant Care Technology, a healthcare technology company; vice president of American HealthTech, a healthcare software company; and a director of operations for Blue Cross Blue Shield of Mississippi, a health insurer. He holds a B.S. in Industrial Engineering from Mississippi State University.
Recent Articles by Keith Speights

Feb 28, 2025
by Keith Speights
How to Invest in Tilray Stock

Feb 26, 2025
by Keith Speights
What Is a Tax Exemption?

Feb 26, 2025
by Keith Speights
Why Madrigal Pharmaceuticals Stock Is Soaring Today

Feb 26, 2025
by Keith Speights
The Best Vanguard ETF to Invest $1,000 in Right Now

Feb 24, 2025
by Keith Speights
Could Buying Amazon Stock Today Set You Up for Life?
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.